107 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
HALO Halozyme Therapeutics, Inc. $16.68 $2.41B N/A
Article Searches
Halo labs to provide update on Bophelo acquisition https://seekingalpha.com/news/3522623-halo-labs-provide-update-bophelo-acquisition?source=feed_news_all Nov 29, 2019 - Halo Labs (OTCQX:AGEEF) will hold a conference call today at 4:00 pm ET to discuss the signing of the Bophelo acquisition and general update on the California strategy due to the large volume of requ
Halo Labs' Q3 Revenue Jumps 99% Year-Over-Year http://feeds.benzinga.com/~r/benzinga/~3/7OkjIpBJ9lg/halo-labs-q3-revenue-jumps-99-year-over-year Nov 15, 2019 -

Halo Labs Inc. (OTC: AGEEF) posted third-quarter revenue of $7.2 million Thursday, up 99% year-over-year. 

The company’s gross profit and gross margin for the quarter were $2.9 million and 41%, respectively.

The cost of goods sold amounted to $4.2 million in the quarter.

Halo Labs reports Q3 results https://seekingalpha.com/news/3519650-halo-labs-reports-q3-results?source=feed_news_all Nov 15, 2019 -
Halozyme Therapeutics Inc (HALO) Q3 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/11/12/halozyme-therapeutics-inc-halo-q3-2019-earnings-ca.aspx?source=iedfolrf0000001 Nov 12, 2019 - HALO earnings call for the period ending September 30, 2019.
Halozyme Therapeutics, Inc. (HALO) CEO Helen Torley on Q3 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4306014-halozyme-therapeutics-inc-halo-ceo-helen-torley-q3-2019-results-earnings-call-transcript?source=feed_sector_healthcare Nov 12, 2019 - Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q3 2019 Earnings Conference Call November 12, 2019 4:30 PM ET Company Participants Albert Kildani - Vice President of Investor Relations and Corporate Communi
Halozyme Therapeutics (HALO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release http://www.zacks.com/stock/news/604507/halozyme-therapeutics-halo-may-report-negative-earnings-know-the-trend-ahead-of-next-weeks-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-604507 Nov 05, 2019 - Halozyme Therapeutics (HALO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HALO: Barclays ups to Equal Weight https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=UD20191105063513 Nov 05, 2019 - Barclays issues rating change for HALO
Bruce Linton-Backed Better Choice Acquires Holistic Pet Foods Company Halo http://feeds.benzinga.com/~r/benzinga/~3/_Y2Gw3kSUVE/bruce-linton-backed-better-choice-acquires-holistic-pet-foods-company-halo Oct 17, 2019 -

Better Choice Company (OTC: BTTR), an animal health and wellness CBD company, said Wednesday it signed a definitive agreement to acquire holistic pet foods company Halo, Purely for Pets.

read more

Halo Acquires Dispensary Software Company Cannpos Services, Announces Private Placement http://feeds.benzinga.com/~r/benzinga/~3/lEg-FNnjvs8/halo-acquires-dispensary-software-company-cannpos-services-announces-private-placement Oct 07, 2019 -

Halo Labs Inc. (OTC: AGEEFsaid Monday it has signed an agreement to purchase all common shares of Cannpos Services Corp.

read more

Roche's New Perjeta Combo Meets Goal in Breast Cancer Study http://www.zacks.com/stock/news/517413/roches-new-perjeta-combo-meets-goal-in-breast-cancer-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-517413 Sep 13, 2019 - Roche's (RHHBY) new fixed-dose combination of Perjeta and Herceptin meets the primary endpoint in the phase III study for treating patients with HER2-positive early breast cancer.

Pages: 123456...11

Page 1>